|
[posting]61949489[/posting]So, morgen ist die Konferenz und dann schauen wir mal was Herr Walker uns zusagen hat... Aclaris Therapeutics to Present at Upcoming Investor Conferences November 12, 2019 WAYNE, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced that management will present at the following conferences: Dr. Neal Walker, President and Chief Executive Officer, together with members from the Company’s R&D team, will present a company overview at SVB Leerink’s 13th Annual POLARxPRESS Bus Tour in New York, New York on Thursday, November 21, 2019. The R&D team will include: Joseph Monahan, Ph.D. - EVP R&D (Head of Discovery) Walter Smith - SVP, R&D Paul Changelian, Ph.D. - VP, Biology Jon Jacobsen, Ph.D. - VP, Chemistry Dr. David Gordon - Chief Medical Officer Dr. Walker will also present a company overview at the Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019 at 3:05 PM ET at the Four Seasons Hotel in Boston, Massachusetts. A live audio webcast of the presentation may be accessed through the Company's web site, www.aclaristx.com, on the 'Events' section. An archived version of the presentation will be available for 30 days. |
|
| aus der Diskussion: | Aclaris Therapeutics (ACRS) - Marktkap: $43 M - Reboundplay |
| Autor (Datum des Eintrages): | MA10 (20.11.19 20:37:47) |
| Beitrag: | 1,745 von 2,342 (ID:61976135) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |